Global Optical Coherence Tomography for Ophthalmology Market 2018-2022
About Optical Coherence Tomography for Ophthalmology
OCT for ophthalmology helps to diagnose various ophthalmic diseases such as age-related macular degeneration, diabetic retinopathy, and cataract. Spectral-domain technology, swept-source technology, and full-field technology are some of the technologies that are used in the OCT products available in the market.
Technavio’s analysts forecast the global optical coherence tomography for ophthalmology market to grow at a CAGR of 6.85% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global optical coherence tomography for ophthalmology market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Optical Coherence Tomography for Ophthalmology Market 2018-2022
Technavio recognizes the following companies as the key players in the global optical coherence tomography for ophthalmology market: Carl Zeiss Meditec, Danaher, Heidelberg Engineering, NIDEK, Optovue, and TOPCON.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing focus toward adaptive optics. Corrective optics techniques like adaptive optics are combined with OCT to improve the transverse resolution of the imaging system. Also, it measures the monochromatic aberrations, which occur in eyes and eventually correct them with the help of sensing of wavefronts and deformable mirrors.”
According to the report, one driver in the market is increasing incidences of ocular diseases. There is an increasing incidence of ocular diseases such as diabetic eye disease, glaucoma, diabetic retinopathy, cataract, corneal scarring, AMD, retinitis, refractive error, keratitis, and blepharitis, which is significantly driving the sales of OCT devices. According to the CDC, in September 2015, diabetic retinopathy and AMD were the major age-related eye diseases in the US. In 2016, according to the CDC, AMD is a leading cause of vision loss and blindness for individuals in the US aged above 65 years.
Further, the report states that one challenge in the market is high cost associated with OCT. The high price of OCT system and excessive cost associated with installation are increasing the cost burden for the end-users. The end-users such as hospitals and clinics, ASCs, and physicians' offices have a limited budget range. Owing to the high cost of OCT systems and installation cost, some end-users are not able to accommodate in their budget allocation, which is affecting the adoption.
Carl Zeiss Meditec, Danaher, Heidelberg Engineering, NIDEK, Optovue, and TOPCON.